ADvantage Therapeutics Inc.
PrivateLast Round
Grant
Sep 26, 2025
Total Funding Raised
$23M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ADvantage Therapeutics Inc. is a biotechnology company that develops novel therapies for neurodegenerative conditions, with a primary focus on Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ADvantage Therapeutics Inc. Comparables
Compare ADvantage Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Klothea Bio, Inc. | 87% | |
| Klotho Therapeutics, Inc. | 85% | |
| Klogene Therapeutics, Inc. | 83% | |
ADvantage Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2025 | ||||
| Seed | Nov 25, 2024 | ||||
| Early Funding | Jul 12, 2023 | ||||
| Seed | Jun 1, 2022 |
Key People
Founding team and executive leadership
ADvantage Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
| National Institute on Aging | Grant |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 45% MoM.
- Oct 9, 2025
Preparing for Phase 1B trial of next-generation Klotho therapeutics.
ADvantage Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ADvantage Therapeutics Inc.'s valuation, stock price, and market status.